, Singapore
210 views
Photo from Shutterstock

GCBC's joint liquidators sell full stake in Cordlife Group

They hold a 9.99% stake in the company.

The joint liquidators of Global Cord Blood Corporation (GCBC) have disposed of their entire stake in the Cordlife Group.

In a bourse filing, Cordlife reported that Margot Maclnnis and John Royale of Grant Thornton Specialist Services disposed of more than 25.5 million shares or 9.99 stake in the company.

Maclnnis, Royale, and Chow Tsz Nga are joint provisional liquidators of GCBC, making them deemed interested in the shares of Cordlife.

GCBC holds an interest in Cordlife through China Stem Cells (East) Company Limited (CSCECL), which owns 25.5 million shares in Cordlife. 

China Stem Cells Holdings Limited (CSCHL), for which GCBC is the sole shareholder, is also the sole shareholder of CSCECL.
 

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.